Discover historical prices for BMTI stock on Yahoo Finance. View daily, weekly or monthly formats back to when stock was issued.

A net loss of $8.2M, or $0.29, per diluted share. For Q2/11, BMTI reported a net loss of $8.2M, or $0.29 per diluted share, compared to a net loss of $7.7M or $0.35 per diluted share for Q2/10. Q2 ...

Is it a worry when the percentage gainers are all low-priced stocks? For some it may be, others will just say it is the normal process. Cybex International, Inc. (NASDAQ: CYBI) is up 23% at $1.47 and ...

Find the latest (BMTI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Take a look at these three top-ranked, best-performing and well-managed mutual funds if you're looking to maximize your retirement portfolio returns. Take advantage of these top-ranked, ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The Therapeutic Goods Administration (TGA) has approved a medical device application for Augment® Bone Graft ...

BioMimetic Therapeutics (Nasdaq:BMTI) is trading at unusually high volume Friday with 3.3 million shares changing hands. It is currently at 10.8 times its average daily volume and trading down 52 ...

NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BioMimetic Therapeutics Inc.

WMGI has completed its acquisition of BioMimetic Therapeutics. The transaction combines BMTI’s biologics platform and pipeline with Wright’s established sales force and product portfolio, to further ...

BioMimetic Therapeutics (Nasdaq:BMTI) hit a new 52-week low Thursday as it is currently trading at $5.32, below its previous 52-week low of $5.33 with 104,571 shares traded as of 11:15 a.m. ET.

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of BioMimetic Therapeutics Inc. (BMTI) NEW YORK-- (BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities firm ...

These three top-ranked, best-performing and well-managed funds can help you maximize your retirement portfolio returns. T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm and leader ...